| Hans-Günter Meyer-Thompson | Buprenorphin
USA. FDA Nixes Approval of Buprenorphine Spray for Pain
USA. FDA Nixes Approval of Buprenorphine Spray for Pain
Today the US Food and Drug Administration (FDA) turned down approval of Buvaya, a buprenorphine sublingual spray (INSYS Therapeutics) for moderate to severe pain resulting from reported safety concerns. (Medscape, 27.07.2018)